Skip to main content
. 2023 May 10;2023(5):CD014682. doi: 10.1002/14651858.CD014682.pub2

RBR‐6pqx4n.

Study name Efficacy of duloxetine in chronic temporomandibular disorder: a randomized clinical trial
Methods Double‐blind, placebo‐controlled, parallel, 2‐arm RCT
12 weeks
Participants Temporomandibular disorder
Presence of pain for at least 3 months
Interventions Duloxetine 60 mg
Placebo
Outcomes Pain intensity
Sleep
Psychosocial profile
Mechanical somatosensory profile
Starting date 01 October 2018
Contact information Dyna Mara Araújo Oliveira Ferreira
Al. Octávio Pinheiro Brisola, 9‐75 17012‐901 Bauru Brazil
dyna.mara@hotmail.com
Notes